Literature DB >> 25369566

Central nervous system complications after liver transplantation: common but mostly transient phenomena.

Martina Bernhardt1, Henning Pflugrad, Annemarie Goldbecker, Hannelore Barg-Hock, Wolfgang Knitsch, Jürgen Klempnauer, Christian P Strassburg, Hartmut Hecker, Karin Weissenborn, Anita Blanka Tryc.   

Abstract

Although central nervous system complications (CNSCs) are common after orthotopic liver transplantation (OLT), standardized prospective studies are still lacking. This prospective study was aimed at determining the incidence of CNSCs, describing their clinical presentations, and establishing predicting factors. One hundred thirty-six adult patients who underwent OLT at Hannover Medical School between December 2008 and June 2011 were included. Weekly examinations were performed by a neurologist during the hospital stay after OLT. Patient data, donor data, and operative and postoperative variables were collected. Patients with cerebral dysfunction after OLT underwent a diagnostic work-up, which included brain imaging and, if necessary, cerebrospinal fluid analysis. Patients with central nervous system (CNS) symptoms but negative imaging and cerebrospinal fluid results and patients with pontine myelinolysis or posterior reversible encephalopathy syndrome were placed in a metabolic-toxic CNSC group, and patients with strokes, intracranial hemorrhaging, or CNS infections were placed in a nonmetabolic CNSC group. Multiple regression analysis was used to identify independent risk factors for the development of metabolic-toxic CNSCs. After excluding two patients that died after OLT without regaining consciousness, forty-four (32.8%) patients developed CNSCs: 37 of these patients (27.6%) had metabolic-toxic CNSCs, and 7 (5.2%) had nonmetabolic CNSCs. Acute-on-chronic liver failure, the number of subsequent surgeries, and primary sclerosing cholangitis were identified as independent predictors for the development of metabolic-toxic CNSCs. Metabolic-toxic CNSCs were associated with prolonged hospital stays, and nonmetabolic CNSCs were associated with higher mortality. In conclusion, CNSCs are common and relevant complications after OLT. Patients after OLT, especially with risk factors, should undergo a regular standardized neurological examination that would allow early detection of these complications.
© 2014 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25369566     DOI: 10.1002/lt.24035

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  8 in total

Review 1.  Neurologic Complications of Transplantation.

Authors:  Rajat Dhar
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

2.  Hepatic encephalopathy before and neurological complications after liver transplantation have no impact on the employment status 1 year after transplantation.

Authors:  Henning Pflugrad; Anita B Tryc; Annemarie Goldbecker; Christian P Strassburg; Hannelore Barg-Hock; Jürgen Klempnauer; Karin Weissenborn
Journal:  World J Hepatol       Date:  2017-04-08

3.  Catatonia After Liver Transplantation.

Authors:  Jason R Tatreau; Sarah L Laughon; Tomasz Kozlowski
Journal:  Ann Transplant       Date:  2018-08-28       Impact factor: 1.530

4.  Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation.

Authors:  Henning Pflugrad; Anita Blanka Tryc; Annemarie Goldbecker; Hannelore Barg-Hock; Christian Strassburg; Jürgen Klempnauer; Heinrich Lanfermann; Karin Weissenborn; Peter Raab
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

5.  Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation.

Authors:  Lukas Laurids Goede; Henning Pflugrad; Birte Schmitz; Heinrich Lanfermann; Anita Blanka Tryc; Hannelore Barg-Hock; Jürgen Klempnauer; Karin Weissenborn; Xiao-Qi Ding
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

6.  Tacrolimus-induced epilepsy with primary membranous nephropathy: A case report.

Authors:  Yan Yang; Lei Zhang; Ying Mo; Rong Ren; Fengmei Wang
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

7.  Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19: A case series.

Authors:  Hanna L Kleiboeker; Margaret R Jorgenson; Jeannina A Smith
Journal:  Transpl Infect Dis       Date:  2022-08-18

8.  Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation.

Authors:  Georg Berding; Karin Weissenborn; Meike Dirks; Ralph Buchert; Ann-Katrin Wirries; Henning Pflugrad; Gerrit M Grosse; Carlotta Petrusch; Christian Schütze; Florian Wilke; Martin Mamach; Linda Hamann; Laura B N Langer; Xiao-Qi Ding; Hannelore Barg-Hock; Jürgen Klempnauer; Christian H Wetzel; Mario Lukacevic; Eike Janssen; Mariella Kessler; Frank M Bengel; Lilli Geworski; Rainer Rupprecht; Tobias L Ross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-12       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.